Viewing Study NCT00720304


Ignite Creation Date: 2025-12-24 @ 9:17 PM
Ignite Modification Date: 2026-05-28 @ 9:10 AM
Study NCT ID: NCT00720304
Status: COMPLETED
Last Update Posted: 2024-08-22
First Post: 2008-07-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Sponsor: Case Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III squamous cell carcinoma of the hypopharynx View
None stage IV squamous cell carcinoma of the hypopharynx View
None stage III squamous cell carcinoma of the larynx View
None stage III verrucous carcinoma of the larynx View
None stage IV squamous cell carcinoma of the larynx View
None stage IV verrucous carcinoma of the larynx View
None stage III squamous cell carcinoma of the lip and oral … View
None stage IV squamous cell carcinoma of the lip and oral … View
None stage III verrucous carcinoma of the oral cavity View
None stage IV verrucous carcinoma of the oral cavity View
None metastatic squamous neck cancer with occult primary squamous cell carcinoma View
None stage III squamous cell carcinoma of the nasopharynx View
None stage IV squamous cell carcinoma of the nasopharynx View
None stage III squamous cell carcinoma of the oropharynx View
None stage IV squamous cell carcinoma of the oropharynx View